Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer
Status:
Not yet recruiting
Trial end date:
2024-01-30
Target enrollment:
Participant gender:
Summary
To investigate dynamic change of gut microbiomes and metabolites, and their effects on immune
modulation. To evaluate the efficacy and safety of TNT with GEN-001 (Lactococcus lactis) and
identify predictive biomarkers for pathologic response in patients with locally advanced
rectal cancer (LARC).